HomepageEarnings Events Newsdesk 2 days ago Pfizer inc (PFE) Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer Pfizer inc (NYSE: PFE) FY 2026 Other Release Merck & Co., Inc. (MRK) Merck to Present New Data Reinforcing Long-Term Efficacy of GARDASIL®9 and GARDASIL® at the EUROGIN International Multidisciplinary HPV Congress 2026 » « Rockwell Automation Inc (ROK) BofA Global Industrials Conference Newsdesk: